Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer

This comparative effectiveness study assesses the numbers needed to treat in targeted trials of agents for newly diagnosed ovarian cancer.

Detalles Bibliográficos
Autores principales: Bartoletti, Michele, Pignata, Sandro, Lorusso, Domenica, Perrone, Francesco, Zara, Diego, Puglisi, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719047/
https://www.ncbi.nlm.nih.gov/pubmed/36459141
http://dx.doi.org/10.1001/jamanetworkopen.2022.45077
_version_ 1784843229197238272
author Bartoletti, Michele
Pignata, Sandro
Lorusso, Domenica
Perrone, Francesco
Zara, Diego
Puglisi, Fabio
author_facet Bartoletti, Michele
Pignata, Sandro
Lorusso, Domenica
Perrone, Francesco
Zara, Diego
Puglisi, Fabio
author_sort Bartoletti, Michele
collection PubMed
description This comparative effectiveness study assesses the numbers needed to treat in targeted trials of agents for newly diagnosed ovarian cancer.
format Online
Article
Text
id pubmed-9719047
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-97190472022-12-22 Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer Bartoletti, Michele Pignata, Sandro Lorusso, Domenica Perrone, Francesco Zara, Diego Puglisi, Fabio JAMA Netw Open Research Letter This comparative effectiveness study assesses the numbers needed to treat in targeted trials of agents for newly diagnosed ovarian cancer. American Medical Association 2022-12-02 /pmc/articles/PMC9719047/ /pubmed/36459141 http://dx.doi.org/10.1001/jamanetworkopen.2022.45077 Text en Copyright 2022 Bartoletti M et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Bartoletti, Michele
Pignata, Sandro
Lorusso, Domenica
Perrone, Francesco
Zara, Diego
Puglisi, Fabio
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
title Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
title_full Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
title_fullStr Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
title_full_unstemmed Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
title_short Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer
title_sort number needed to treat in trials of targeted therapies for advanced ovarian cancer
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719047/
https://www.ncbi.nlm.nih.gov/pubmed/36459141
http://dx.doi.org/10.1001/jamanetworkopen.2022.45077
work_keys_str_mv AT bartolettimichele numberneededtotreatintrialsoftargetedtherapiesforadvancedovariancancer
AT pignatasandro numberneededtotreatintrialsoftargetedtherapiesforadvancedovariancancer
AT lorussodomenica numberneededtotreatintrialsoftargetedtherapiesforadvancedovariancancer
AT perronefrancesco numberneededtotreatintrialsoftargetedtherapiesforadvancedovariancancer
AT zaradiego numberneededtotreatintrialsoftargetedtherapiesforadvancedovariancancer
AT puglisifabio numberneededtotreatintrialsoftargetedtherapiesforadvancedovariancancer

Ejemplares similares